Psychosocial treatment approaches to difficult-to-treat depression

Medical Journal of Australia

Volumn 1, Issue , 2012, Pages 52-55

  Casey, Melissa F ^a   Perera, Dinali N ^b   Clarke, David M ^b  

^a Southern Health   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANHEDONIA; ARTICLE; BRIEF PSYCHODYNAMIC PSYCHOTHERAPY; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; FAMILY THERAPY; HOPELESSNESS; HUMAN; INTERPERSONAL PSYCHOTHERAPY; META ANALYSIS (TOPIC); PATIENT COMPLIANCE; PROTOCOL COMPLIANCE; PSYCHOEDUCATION; PSYCHOSOCIAL ENVIRONMENT; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF ESTEEM; SYSTEMATIC REVIEW (TOPIC);

EID: 84908205290     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mjao12.10629     Document Type: Article

References (43)

1. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53: 649-659.
2. Keitner GI, Mansfield AK. Management of treatment-resistant depression. Psychiatr Clin North Am 2012; 35: 249-265.
3. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002; 63: 963-971.
4. Thase ME. Treatment-resistant depression: prevalence, risk factors, and treatment strategies. J Clin Psychiatry 2011; 72: e18.
5. Jenkins E, Goldner EM. Approaches to understanding and addressing treatment-resistant depression: a scoping review. Depress Res Treat Epub 2012; Apr 18. doi:10.1155/2012/469680.
6. Shelton RC, Osuntokun O, Heinloth AN, Corya SA. Therapeutic options for treatment-resistant depression. CNS Drugs 2010; 24: 131-161.
7. Trivedi MH, Daly EJ. Treatment strategies and tactics for treatment-resistant depression. US Psychiatry 2007; 17-20. http://www.touchbriefings.com/pdf/2592/trivedi.pdf (accessed Sep 2012).
8. Chan HN, Mitchell PB, Loo CKA, Harvey SB. Pharmacological treatment approaches to difficult-to-treat depression. MJA Open 2012; 1 Suppl 4: 44-47.
9. Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007; 52: 46-54.
10. Australian Psychological Society. Evidence-based psychological interventions in the treatment of mental disorders: a literature review. 3rd ed. Melbourne: APS, 2010.
11. Matsunaga M, Okamoto Y, Suzuki S, et al. Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy. BMC Psychiatry 2010; 10: 22.
12. Trivedi RB, Nieuwsma JA, Williams JW. Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review. J Gen Intern Med 2011; 26: 643-650.
13. Little A. Treatment-resistant depression. Am Fam Physician 2009; 80: 167-172.
14. Fitzgerald PB. Non-pharmacological biological treatment approaches to difficult-to-treat depression. MJA Open 2012; 1 Suppl 4: 48-51.
15. Maalouf FT, Atwi M, Brent DA. Treatment-resistant depression in adolescents: review and updates on clinical management. Depress Anxiety 2011; 28: 946-954.
16. Hölzel L, Härter M, Reese C, Kriston L. Risk factors for chronic depression — a systematic review. J Affect Disord 2011; 129: 1-13.
17. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Brit J Psychiatry Suppl 1996; (30): 17-30.
18. Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry 2001; 62 Suppl 16: 18-25.
19. Tiller JWG. Depression and anxiety. MJA Open 2012; 1 Suppl 4: 28-31.
20. Dudek D, Rybakowski JK, Siwek M, et al. Risk factors of treatment resistance in major depression: association with bipolarity. J Affect Disord 2010; 126: 268-271.
21. Moore RG, Garland A. Cognitive therapy for chronic and persistent depression. Chichester, UK: John Wiley and Sons, 2003.
22. Katon WJ, Lin EHB, Russo J, et al. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med 2004; 19: 1192-1199.
23. Katon WJ. The many faces of depression in primary care. J Gen Intern Med 2004; 19: 893-895.
24. Clarke DM, Cook K, Smith GC, Piterman L. What do general practitioners think depression is? A taxonomy of distress and depression for general practice. Med J Aust 2008; 188 (12 Suppl): S110-S113.
25. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2010; 167 Suppl: A34.
26. Papakostas GI, Petersen T, Homberger CH, et al. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. Ann Clin Psychiatry 2007; 19: 5-8.
27. Cohen NL, Ross EC, Bagby RM, et al. The 5-factor model of personality and antidepressant medication compliance. Can J Psychiatry 2004; 49: 106-113.
28. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Med Care 1995; 33: 67-74.
29. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164-172.
30. Teasdale JD. Cognitive vulnerability to persistent depression. Cogn Emot 1988; 2: 247-274.
31. Eisendrath S, Chartier M, McLane M. Adapting mindfulness-based cognitive therapy for treatment-resistant depression: a clinical case study. Cogn Behav Pract 2011; 18: 362-370.
32. Kenny MA, Williams JM. Treatment-resistant depressed patients show a good response to mindfulness-based cognitive therapy. Behav Res Ther 2007; 45: 617-625.
33. Wijeratne C, Sachdev P. Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry 2008; 42: 751-762.
34. Abbass AA. Intensive short-term dynamic psychotherapy of treatment-resistant depression: a pilot study. Depress Anxiety 2006; 23: 449-452.
35. Bannan N. Multimodal therapy of treatment resistant depression: a study and analysis. Int J Psychiatry Med 2005; 35: 27-39.
36. Eisendrath SJ, Delucchi K, Bitner R, et al. Mindfulness-based cognitive therapy for treatment-resistant depression: a pilot study. Psychother Psychosom 2008; 77: 319-320.
37. Pampallona S, Bollini P, Tibaldi G, et al. Patient adherence in the treatment of depression. Br J Psychiatry 2002; 180: 104-109.
38. Scott J, Palmer S, Paykel E, et al. Use of cognitive therapy for relapse prevention in chronic depression. Br J Psychiatry 2003; 182: 221-227.
39. Schramm E, Schneider D, Zobel I, et al. Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. J Affect Disord 2008; 109: 65-73.
40. Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 281: 39-45.
41. Ravitz P, McBride C, Maunder R. Failures in interpersonal psychotherapy (IPT): factors related to treatment resistances. J Clin Psychol 2011; 67: 1129-1139.
42. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 2004; 72: 31-40.
43. Barnhofer T, Crane C, Hargus E, et al. Mindfulness-based cognitive therapy as a treatment for chronic depression: a preliminary study. Behav Res Ther 2009; 47: 366-373.